Stay updated on PAC-1 in Refractory Metastatic Kidney Cancer Clinical Trial
Sign up to get notified when there's something new on the PAC-1 in Refractory Metastatic Kidney Cancer Clinical Trial page.
![Latest website image capture](/pages/_next/image?url=https%3A%2F%2Fs3.us-west-2.amazonaws.com%2Fvp-files-ore%2Fresources%2F12months%2FmAaY8KvK3lNJ6zzKjE6xYV3QAs8.uncropped.jpg&w=3840&q=75)
Latest updates to the PAC-1 in Refractory Metastatic Kidney Cancer Clinical Trial page
- CheckyesterdayNo Change Detected
- Check2 days agoNo Change Detected
- Check3 days agoNo Change Detected
- Check4 days agoNo Change Detected
- Check5 days agoNo Change Detected
- Check6 days agoChange DetectedThe website has been updated to Revision v2.9.7 from v2.9.6.SummaryDifference0.1%
- Check20 days agoChange DetectedThe value of Revision has been updated from v2.9.5 to v2.9.6, indicating a recent revision in the content of the webpage.SummaryDifference0.1%
- Check25 days agoChange DetectedThe value of Revision has been updated from v2.9.3 to v2.9.5, indicating a recent revision in the content of the webpage.SummaryDifference0.1%
- Check26 days agoChange DetectedThe value of Revision has been updated from v2.9.1 to v2.9.3, indicating a recent revision in the content of the webpage.SummaryDifference0.1%
- Check27 days agoChange DetectedThe value 'Show more Show more Revision: v2.9.0' has been updated to 'Show less Genetic and Rare Diseases Information Center resources: Renal Cell Carcinoma Clear Cell Renal Cell Carcinoma Drug Information available for: Nivolumab FDA Drug and Device Resources Show less'. This change represents an update in the information displayed on the webpage regarding resources related to Renal Cell Carcinoma and Drug Information available for Nivolumab.SummaryDifference19%
- Check31 days agoChange DetectedThe value of Revision has been updated from v2.8.1 to v2.9.0, indicating a recent change in the version of the webpage content.SummaryDifference3%
Stay in the know with updates to PAC-1 in Refractory Metastatic Kidney Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the PAC-1 in Refractory Metastatic Kidney Cancer Clinical Trial page.